TLR4 and congestive heart failure: In addition, in both of the sham and CHF myocytes, the pre‐treatment with anti‐TLR4 antibodies (5–10 μg/ml) significantly inhibited the binding of FITC‐LPS and OG‐HSP60 (Fig. 6B and C), suggesting that FITC‐LPS and OG‐HSP60 were bound to TLR4.